Target intelligence / Profile preview

Wnt family member 2 mRNA 3' untranslated region (WNT2 mRNA 3'UTR)

Target
WNT2 mRNA 3'UTR
Molecular classification
Messenger RNA regulatory element, RNA
01

Overview

The Wnt family member 2 (WNT2) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the WNT2 transcript that governs its stability, localization, and translation efficiency (UniProt P09544). WNT2 itself is a secreted glycoprotein that activates the canonical Wnt/beta-catenin signaling pathway, which is essential for embryonic development and adult tissue homeostasis. In various malignancies, including colorectal, esophageal, and non-small cell lung cancers, WNT2 is frequently overexpressed, driving tumor progression, epithelial-mesenchymal transition (EMT), and metastasis (PMID: 31485248). The 3'UTR contains binding sites for several microRNAs (miRNAs) and RNA-binding proteins that act as post-transcriptional regulators; for instance, miR-148a and miR-27a have been shown to bind this region to suppress WNT2 expression (PMID: 29113355). Consequently, the WNT2 mRNA 3'UTR is considered a therapeutic target for RNA-based interventions, such as antisense oligonucleotides or miRNA mimics, aimed at reducing oncogenic Wnt signaling. However, therapeutic development must address challenges such as off-target effects and the maintenance of normal Wnt-mediated tissue repair processes.

Other names
WNT2 3'UTRWingless-type MMTV integration site family member 2 3'UTRIRP mRNA 3'UTRWNT2 3-prime untranslated region
02

Mechanism of action

RNA interference-mediated degradation or translational repression of WNT2 mRNA via sequence-specific binding to the 3'UTR.

03

Biological functions

Regulation of mRNA stabilityTranslational regulationWnt signaling pathway modulationPost-transcriptional gene regulation
04

Disease associations

CancerColorectal cancerNon-small cell lung cancerGastric cancerEsophageal cancerFibrosis
05

Safety considerations

Off-target effects on other mRNA transcripts with sequence homologyInhibition of physiological Wnt signaling in stem cell niches and healthy tissuesSystemic toxicity associated with RNA delivery vehicles (e.g., lipid nanoparticles)
06

Interacting drugs

miR-148a-3p mimic (experimental)

3 more in the full profile.

07

Biomarkers

WNT2 mRNA expression levelsWNT2 protein expression levelsmiR-148a-3p expression levelsmiR-27a-3p expression levels

Beyond the preview

Go deeper on Wnt family member 2 mRNA 3' untranslated region (WNT2 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wnt family member 2 mRNA 3' untranslated region (WNT2 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call